학술논문
P2.06-026 A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress: Topic: Mesothelioma and SCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1087-S1087
Subject
Language
ISSN
1556-0864